Similar articles

• [Ovulation inhibitors and tumors].

  Freundl G, Brossmann H. Freundl G, et al. Dtsch Med Wochenschr. 1985 Aug 30;110(35):1346-50. doi: 10.1055/s-2008-1069009. Dtsch Med Wochenschr. 1985. PMID: 3896722 Review. German. No abstract available.
• Oral contraceptives and cancer.

  Edgren RA. Edgren RA. Int J Fertil. 1991;36 Suppl 3:37-50. Int J Fertil. 1991. PMID: 1687403 Review.
• Oral contraceptives and cancer.

  Holck S, Ebeling K. Holck S, et al. Arch Geschwulstforsch. 1986;56(2):155-67. Arch Geschwulstforsch. 1986. PMID: 3518652 Review.
• [Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology].

  Hammerstein J, Bolt HM, Breckwoldt M, von Eickstedt KW, Elger W, Hoffmann B, Köbberling J, Knorr D, Nieschlag E, Nocke W, et al. Hammerstein J, et al. Dtsch Med Wochenschr. 1987 May 29;112(22):897-9. Dtsch Med Wochenschr. 1987. PMID: 3034544 German. No abstract available.
• [Does the "pill" promote the development of tumors?].

  Lauritzen C. Lauritzen C. Med Klin. 1980 Aug 1;75(16):6-7. Med Klin. 1980. PMID: 6251352 German. No abstract available.